LONDON--(BUSINESS WIRE)--Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that Yuval Cohen, Chief Executive Officer, will deliver a presentation at the annual JAFCO Bio Conference on Tuesday November 13th. The conference, by invitation only, will be held from November 12 - 13, 2006, at the Shinjuku Hilton Hotel in Tokyo.
